| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |